Thiothixene and trifluoperazine in acutely disturbed schizophrenic patients.
In acutely disturbed newly admitted patients at Neuropsychiatric Unit, Karachi, the efficacy of thiothixene is not significantly different as compared to trifluoperazine. In trifluoperazine group also all the target symptoms improved while 'depressive mood' and 'suspiciousness' did not change significantly. In thiothixene group significant improvement was noticed on all the target symptoms except 'tension' and 'depressive mood'. The ethnic or genetic make up of the patient population was concluded to be the reason for non-effectiveness of thisthixene on effective psychopathology in acute schizophrenia. The extra-pyramidal side effects were clinically more pronounced in thiothixene group.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy*; D013888:Thiothixene / Q000009:adverse effects / Q000627:therapeutic use*; D014268:Trifluoperazine / Q000009:adverse effects / Q000627:therapeutic use*
D014268:Trifluoperazine; D013888:Thiothixene